American Journal of Cardiology
Volume 103, Issue 12 , Pages 1672-1674 , 15 June 2009

Major Adverse Cardiac Events at Follow-Up After Bare-Metal Stenting Versus Drug-Eluting Stenting in ST-Elevated Myocardial Infarction

  • Bredy Pierre-Louis, MD

      Affiliations

    • Department of Medicine, Cardiology Division, New York Medical College, Valhalla, New York
    • ,
  • Wilbert S. Aronow, MD

      Affiliations

    • Department of Medicine, Cardiology Division, New York Medical College, Valhalla, New York
    • Corresponding Author InformationCorresponding author: Tel.: (914)-493-5311; fax: (914)-235-6274
    • ,
  • Chandrasekar Palaniswamy, MD

      Affiliations

    • Department of Medicine, Cardiology Division, New York Medical College, Valhalla, New York
    • ,
  • Tarunjit Singh, MD

      Affiliations

    • Department of Medicine, Cardiology Division, New York Medical College, Valhalla, New York
    • ,
  • Chul Ahn, PhD

      Affiliations

    • Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, Texas
    • ,
  • Amit Asija, MD

      Affiliations

    • Department of Medicine, Cardiology Division, New York Medical College, Valhalla, New York
    • ,
  • Melvin B. Weiss, MD

      Affiliations

    • Department of Medicine, Cardiology Division, New York Medical College, Valhalla, New York
    • ,
  • Kumar Kalapatapu, MD

      Affiliations

    • Department of Medicine, Cardiology Division, New York Medical College, Valhalla, New York
    • ,
  • Anthony L. Pucillo, MD

      Affiliations

    • Department of Medicine, Cardiology Division, New York Medical College, Valhalla, New York
    • ,
  • Craig E. Monsen, MD

      Affiliations

    • Department of Medicine, Cardiology Division, New York Medical College, Valhalla, New York

Received 23 December 2008 ,Revised 10 February 2009 ,Accepted 10 February 2009.

References 

  1. Lip GYH, Blann AD. Thrombogenesis and fibrinolysis in acute coronary syndromes: important facets of a prothrombotic or hypercoagulable state. J Am Coll Cardiol. 2000;36:2044–2046
  2. Merlini PA, Bauer KA, Oltrona L, Arddissino D, Spinola A, Cattaneo M, et al. Thrombin generation and activity during thrombolysis and concomitant heparin therapy in patients with acute myocardial infarction. J Am Coll Cardiol. 1995;25:203–209
  3. Gurbel PA, Serebruany VL, Shustov AR, Bahr RD, Carpo C, Ohman EM, et al. Effects of reteplase and alteplase on platelet aggregation and major receptor expression during the first 24 hours of acute myocardial infarction. J Am Coll Cardiol. 1998;311:466–473
  4. Dunn CJ, Goa KL. Tenecteplase: a review of its pharmacology and therapeutic efficacy in patients with acute myocardial infarction. Am J Cardiovascular Drugs. 2001;1:51–66
  5. Kirtane AJ, Weisbord A, Karmpaliotis D, Murphy SA, Giugliano RP, Cannon CP, et al Relation of impaired thrombolysis in myocardial infarction myocardial perfusion grades to residual thrombus following the restoration of epicardial patency in ST-elevation myocardial infarction. Am J Cardiol. 2005;95:224–227
  6. Harjai KJ, Grines C, Stone GW, Boura J, Turco M, Brodie B, et al. Frequency, determinants, and clinical implications of residual intracoronary thrombus following primary angioplasty for acute myocardial infarction. Am J Cardiol. 2003;92:377–382
  7. Hong M-K, Mintz GS, Lee CW, Park D-W, Park K-M, Lee B-K, et al Late stent malposition after drug-eluting stent implantation: an intravascular ultrasound analysis with long-term follow-up. Circulation. 2006;113:414–419
  8. Hong M-K, Mintz GS, Lee CW, Lee BK, Kim Y-H, Lee S-W, et al Incidence, mechanism, predictors, and long-term prognosis of late stent malposition after bare-metal stent implantation. Circulation. 2004;109:881–886
  9. Fujimoto H, Tao S, Mitani H, Ito S, Fujimoto Y, Maehara A, et al. The efficacy of bare metal stent implantation for patients with acute myocardial infarction in the drug-eluting stent era. J Cardiol. 2008;51:189–195
  10. Brodie BR, Stuckey T, Downey W, Humphrey A, Nussbaum M, Laurent S, et al Outcomes with drug-eluting versus bare-metal stents in acute ST-elevation myocardial infarction: results from the Strategic Transcatheter Evaluation of New Therapies (STENT) Group. Catheter Cardiovascular Interv. 2008;72:893–900
  11. Mauri L, Hsieh W-H, Massaro JM, Ho KKL, D'Agostino R, Cutlip DE. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med. 2007;356:1020–1029
  12. Luscher TF, Steffel J, Eberli FR, Joner M, Nakazawa G, Tanner FC, et al. Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications. Circulation. 2007;115:1051–1058
  13. Mauri L, Silbaugh TS, Garg P, Wolf RE, Zelevinsky K, Lovett A, et al. Drug-eluting or bare-metal stents for acute myocardial infarction. N Engl J Med. 2008;359:1330–1342

PII: S0002-9149(09)00597-9

doi: 10.1016/j.amjcard.2009.02.016

American Journal of Cardiology
Volume 103, Issue 12 , Pages 1672-1674 , 15 June 2009

Article Tools